bioAffinity Technologies, Inc. (BIAF) is in Healthcare, Diagnostics & Research, based in United States, listed on NasdaqCM. Market cap 6.58M USD. 52-week range 4.56 to 80.70 USD. Data as of 2026-10-09.
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States. The company operates through two segments: Diagnostic Research and Development; and Laboratory Services. The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics ...